Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 5.42M $162.41M June 30, 2014
BlackRock Fund Advisors 4.70M $111.40M Sept. 30, 2014
Vanguard 4.40M $132.03M June 30, 2014
FMR 4.22M $111.61M March 31, 2014
Visium Asset Management 3.40M $52.50M March 31, 2013
Wells Fargo & Company 2.71M $55.10M June 30, 2012
STATE STREET CORPORATION 2.35M $70.42M June 30, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.23M $52.93M Sept. 30, 2014
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
BlackRock Institutional Trust Company, N.A. 1.84M $43.54M Sept. 30, 2014
Jennison Associates 1.72M $51.63M June 30, 2014
Inves 1.66M $43.80M March 31, 2014
TCW 1.66M $42.96M Sept. 30, 2012
ALLIANCEBERNSTEIN 1.61M $32.97M Dec. 31, 2012
Ameriprise Financial 1.57M $47.22M June 30, 2014
Apex Capital 1.49M $29.61M June 30, 2013
Ranger Investment Management 1.47M $30.22M Dec. 31, 2012
DIMENSIONAL FUND ADVISORS 1.43M $42.89M June 30, 2014
CITADEL ADVISORS 1.42M $29.19M Sept. 30, 2013
ING Investment Management Co Address: 10 State House Square 1.41M $28.42M Dec. 31, 2011
Name Highfields Capital Management 1.40M $41.99M June 30, 2014
Luther King Capital Management Corporation 1.35M $27.66M Dec. 31, 2012
RS INVESTMENT MANAGEMENT 1.33M $35.10M March 31, 2014
LORD, ABBETT & CO 1.27M $38.18M June 30, 2014
Ascend Capital 1.20M $24.48M Sept. 30, 2013
Millennium Management 1.18M $31.30M March 31, 2014
S.A.C. Capital Advisors 1.14M $29.58M Sept. 30, 2012
FRIESS ASSOCIATES 1.13M $27.76M March 31, 2012
HealthCor Management 1.11M $22.77M Sept. 30, 2013

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 1.57M $34.19M
Nuveen Asset Management June 30, 2011 1.27M $27.63M
Damian Sousa June 30, 2011 1.21M $26.35M
Thompson, Siegel, & Walmsley Dec. 31, 2010 1.20M $24.10M